03123nas a2200277 4500008004100000245008200041210006900123260001800192300001100210490000600221520226500227653000602492653003602498653000802534653003102542653003702573653001702610653001502627653002102642100002202663700002202685700002402707700002202731700002402753856006802777 2016 eng d00aCharacterization of Anticancer Principles of Celosia argentea (Amaranthaceae)0 aCharacterization of Anticancer Principles of Celosia argentea Am cFebruary 2016 a97-1040 v83 a

Background: An Indian origin, Celosia argentea is a weed growing during rainy season traditionally claimed for treating several ailments. Early researches on C. argentea were focused on the anti-cancer screening of seeds, with few reports on aerial parts. Objective: To isolate and characterize bioactive compounds of aerial parts of C. argentea and evaluate their anticancer potential. Materials and Methods: The methanolic aerial part extract was fractionated on column chromatography using chloroform: methanol mixture. The fractions; 80:20 and 95:5 were purified on MCI-HP20 HPLC column. Chromatographically pure compounds were pooled, concentrated and characterized spectroscopically. The compounds were further screened for antioxidant and cytotoxic potential. Results: Isolated compounds were confirmed as: (1) Luteolin-7-O-glucoside and (2) phenolic, 1-(4-hydroxy- 2-methoxybenzofuran-5-yl)-3-phenylpropane-1,3-dione. Both exhibited significant antioxidant potential with IC50 values of 20.80 and 21.30 μg/ml for 2,2-diphenyl-1-picrylhydrazyl assay (***P < 0.001) and significant Trolox equivalent antioxidant capacity (TEAC) values for 2,2’-azino-bis(3- ethylbenzthiazoline-6-sulphonic acid) (*P < 0.05) and ferric reducing antioxidant potential assay (****P < 0.0001). In 3(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl-tetrazoliumbromide assay, Compound 1 and 2 showed potent cytotoxicity against SiHa, HCT, MCF-7 cancer cell lines at 20 μg/ml (****P < 0.0001) and 18 μg/ml (**P < 0.01), respectively, without affecting the normal Vero cells. Both compounds enabled maximum reduction in cell viability at 50 μg/ml against HT-29 (***P < 0.001) and MCF-7 cell lines (**P < 0.01) in try pan blue viability assay. Apoptosis occurred at concentrations of 47.33 ± 0.8 μg/ml and 56.28 ± 1.2 μg/ml for Compound 1 and 35.15 ± 0.4 μg/ml and 28.05 ± 0.3 μg/ml for Compound 2 for HT-29 and MCF-7 respectively. Conclusion: A novel anticancer phenolic compound; (1-(4-hydroxy-2-methoxybenzofuran-5-yl)-3-phenylpropane- 1,3-dione), isolated from aerial parts of C. argentea was a valuable finding of the research.

10a210a2-diphenyl-1-picrylhydrazylDPPH10a3(410a5-dimethylthiazol-2- yl)-210a5-diphenyl-tetrazoliumbromideMTT10aanti-oxidant10aanticancer10aCelosia argentea1 aRub, Rukhsana, A.1 aPati, Manohar, J.1 aSiddiqui, Areej, A.1 aMoghe, Alpana, S.1 aShaikh, Nasreen, N. uhttps://www.phcogres.com/article/2016/8/2/1041030974-8490172659